[Results of an international multicenter, randomized, double-blind, placebo-controlled study assessing the efficacy and safety of sequential therapy with Mexidol and Mexidol FORTE 250 in patients with chronic brain ischemia (MEMO)].
A I FedinV V ZakharovM M TanashyanE I ChukanovaE N MadzhidovaL A ShchepankevichOlga Dmitrievna OstroumovaPublished in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2021)
The validity and expediency of the use of Mexidol and Mexidol FORTE 250 in the treatment of patients with CBI has been demonstrated.